Novel molecular signatures in mononuclear cell populations from patients with systemic lupus erythematosus

被引:17
|
作者
Olferiev, Mikhail [1 ]
Jacek, Elzbieta [1 ]
Kirou, Kyriakos A. [1 ]
Crow, Mary K. [1 ]
机构
[1] Hosp Special Surg, Mary Kirkland Ctr Lupus Res, 535 East 70th St, New York, NY 10021 USA
关键词
Systemic lupus erythematosus; Gene expression analysis; Microarray; Type I interferon; T effector cells; Wnt/beta-catenin; REGULATORY T-CELLS; I INTERFERON; MICROARRAY ANALYSIS; GENE-EXPRESSION; PROTEIN-KINASE; UP-REGULATION; BETA-CATENIN; B-CELL; CANCER; ACTIVATION;
D O I
10.1016/j.clim.2016.08.018
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
To gain novel insights into the immunopathogenesis of systemic lupus erythematosus we have analyzed gene expression data from isolated CD4(+) T cells, CD8(+) T cells, CD19(+) B cells, and CD56(+) NK-cell enriched peripheral blood cell fractions from patients and healthy donors. As predicted, type I interferon-inducible gene transcripts are overexpressed in all populations. Transcripts preferentially expressed in SLE CD4(+) and CD8(+) T cells include those associated with Tregulatory and Th17 effector cell programs, respectively, but in each case additional transcripts predicted to limit differentiation of those effector cells are detected. Evidence for involvement of the Wnt/beta-catenin pathway was observed in both B and T cell fractions, and novel transcripts were identified in each cell population. These data point to disrupted T effector cell differentiation and the Wnt/beta-catenin pathway as contributors to immune dysfunction in SLE while further supporting a central role for the type I interferon pathway in lupus. (C) 2016 Published by Elsevier Inc.
引用
收藏
页码:34 / 43
页数:10
相关论文
共 50 条
  • [1] Novel insights into molecular signatures and pathogenic cell populations shared by systemic lupus erythematosus and vascular dementia
    Chen, Jing
    Zhao, Xiao'feng
    Huang, Cheng
    Lin, Jia'xing
    FUNCTIONAL & INTEGRATIVE GENOMICS, 2023, 23 (04)
  • [2] Novel insights into molecular signatures and pathogenic cell populations shared by systemic lupus erythematosus and vascular dementia
    Jing Chen
    Xiao’feng Zhao
    Cheng Huang
    Jia’xing Lin
    Functional & Integrative Genomics, 2023, 23
  • [3] Shared molecular signatures between systemic lupus erythematosus and osteoporosis
    Yuan, Xin
    Zheng, Ze-mao
    Lai, Weinan
    Environmental Toxicology, 2024, 39 (10) : 4744 - 4753
  • [4] Novel molecular targets for systemic lupus erythematosus
    Marino, M
    Rossi, M
    Ruvo, M
    Fassina, G
    CURRENT DRUG TARGETS, 2002, 3 (03) : 223 - 228
  • [5] Urinary mononuclear cell and disease activity of systemic lupus erythematosus
    Chan, RWY
    Lai, FM
    Li, EKM
    Tam, LS
    Chung, KY
    Chow, KM
    Li, PKT
    Szeto, CC
    LUPUS, 2006, 15 (05) : 262 - 267
  • [6] Overexpression of Aiolos in Peripheral Blood Mononuclear Cell Subsets from Patients with Systemic Lupus Erythematosus and Rheumatoid Arthritis
    Xinze Cai
    Xudong Liu
    Shuyan Du
    Xiaoxue Xu
    Ang Liu
    Xin Ge
    Ying Qiao
    Yi Jiang
    Biochemical Genetics, 2016, 54 : 73 - 82
  • [7] Overexpression of Aiolos in Peripheral Blood Mononuclear Cell Subsets from Patients with Systemic Lupus Erythematosus and Rheumatoid Arthritis
    Cai, Xinze
    Liu, Xudong
    Du, Shuyan
    Xu, Xiaoxue
    Liu, Ang
    Ge, Xin
    Qiao, Ying
    Jiang, Yi
    BIOCHEMICAL GENETICS, 2016, 54 (01) : 73 - 82
  • [8] SPONTANEOUS TRANSFORMATION OF MONONUCLEAR-CELLS FROM SYSTEMIC LUPUS-ERYTHEMATOSUS PATIENTS
    PHILLIPS, PE
    ANDERSON, K
    ARTHRITIS AND RHEUMATISM, 1980, 23 (06): : 731 - 732
  • [9] Novel molecular targets in the treatment of systemic lupus erythematosus
    Crispin, Jose C.
    Tsokos, George C.
    AUTOIMMUNITY REVIEWS, 2008, 7 (03) : 256 - 261
  • [10] T-CELL POPULATIONS AND SYSTEMIC LUPUS-ERYTHEMATOSUS
    HARTUNG, K
    RUSTIGE, F
    LANG, B
    PETER, HH
    PICHLER, WJ
    DEICHER, H
    ZEITSCHRIFT FUR RHEUMATOLOGIE, 1988, 47 (04): : 283 - 283